flibanserin

flibanserin (trade name girosa) was an investigational compound studied as an oral daily treatment to improve sexual desire in pre-menopausal women suffering from decreased sexual desire—a medical condition known as hypoactive sexual desire disorder (hsdd) icd-10 f52.0. marketing was terminated in October 2010 following a negative report from the fda.